BioCryst Pharmaceuticals Down 23.3% Since SmarTrend Downtrend Call (BCRX)
August 28, 2015 at 11:15 AM EDT
SmarTrend identified a Downtrend for BioCryst Pharmaceuticals (NASDAQ:BCRX) on August 6th, 2015 at $14.59. In approximately 3 weeks, BioCryst Pharmaceuticals has returned 23.34% as of today's recent price of...